ArticleNutrients2025

2,5-Dihydroxybenzoic Acid Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Targeting the CCL2-CCR2 Axis to Reduce Lipid Accumulation.

Chien-Yun Hsiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.